Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 129

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 129
---
 similar communication) (it being understood that Aadi’s board of directors may refrain from taking a position with respect to an                                                 
 acquisition proposal until 5:30 p.m., Pacific time, on the 10th business day after the commencement of a tender or exchange offer in connection with such acquisition proposal without such action being considered a violation of the Divestiture 
 Agreement);                                                                                                                                                                                                                                        |

| • |     | fail to include the Aadi board of directors’ recommendation in this proxy statement (we refer to the 
 preceding actions as an “Aadi Board Recommendation Change”); or                                      |

| • |     | cause or permit Aadi or Aadi Sub to enter into an Alternative Acquisition Agreement. |

At any time prior to obtaining the requisite stockholder approval, other than in connection with an acquisition proposal, Aadi’s board of directors may effect an Aadi Board Recommendation Change in respect to an Intervening Event (as defined below) if and only if:

| • |     | Aadi’s board of directors determines in good faith (after consultation with its financial advisor and                                  
 outside legal counsel) that the failure to take such action could reasonably be expected to be inconsistent with its fiduciary duties; |

| • |     | Aadi or Aadi Sub has provided prior written notice to Kaken that Aadi’s board of directors has (1) made                                                                                                                                           
 the determination that the failure to take effect an Aadi Board Recommendation Change could reasonably be expected to be inconsistent with its fiduciary duties and (2) resolved to effect an Aadi Board Recommendation Change, which notice will 
 describe the Intervening Event in reasonable detail; and                                                                                                                                                                                          |

| • |     | prior to effecting such Aadi Board Recommendation Change, Aadi, Aadi Sub and their representatives, until 5:00                                                                                                                                       
 p.m. Pacific time on the fifth business day following the date of delivery of such written notice, have (1) negotiated with Kaken and its representatives in good faith (to the extent that Kaken requests to negotiate) to make such adjustments to 
 the terms and conditions of the Divestiture Agreement and the other transaction documents so that Aadi’s board of directors no longer determines in good faith that the failure to make an Aadi Board Recommendation Change in response to such      
 Intervening Event could reasonably be expected to be inconsistent with its fiduciary duties, and (2) permitted Kaken and its representatives to negotiate with Aadi and its representatives throughout such period and to